Top

Published in:

01-07-2020 | Multiple Sclerosis | COVID-19

Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study

Authors: Gloria Dalla Costa, Letizia Leocani, Xavier Montalban, Ana Isabel Guerrero, Per Soelberg Sørensen, Melinda Magyari, Richard J. B. Dobson, Nicholas Cummins, Vaibhav A. Narayan, Matthew Hotopf, Giancarlo Comi, on behalf of the RADAR-CNS consortium

Published in: Neurological Sciences | Issue 7/2020

Abstract

We assessed the prevalence and impact of COVID-19 among multiple sclerosis (MS) patients across Europe by leveraging participant data collected as part of the ongoing EU IMI2 RADAR-CNS major programme aimed at finding new ways of monitoring neurological disorders using wearable devices and smartphone technology. In the present study, 399 patients of RADAR-MS have been included (mean age 43.9 years, 60.7% females) with 87/399 patients (21.8%) reporting major symptoms suggestive of COVID-19. A trend for an increased risk of COVID-19 symptoms under alemtuzumab and cladribine treatments in comparison to injectables was observed. Remote monitoring technologies may support health authorities in monitoring and containing the ongoing pandemic.

Available only for authorised users

Zhou P, Yang XL, Wang XG et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270–273CrossRefPubMedCentral

Ranjan Y, Rashid Z, Stewart C et al (2019) RADAR-base: open source mobile health platform for collecting, monitoring, and analyzing data using sensors, wearables, and mobile devices. JMIR Mhealth Uhealth 7(8):e11734CrossRefPubMedCentral

World Health Organization (2020) Surveillance case definitions for human infection with novel coronavirus (nCoV): interim guidance v1, January 2020. World Health Organization. https://apps.who.int/iris/handle/10665/330376. License: CC BY-NC-SA 3.0 IGO. Accessed 1 Jul 2020

Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506CrossRefPubMedCentral

Firth D (1993) Bias reduction of maximum likelihood estimates. Biometrika [Internet]. 80(1):27–38CrossRef

Lachmann A, Jagodnik KM, Giorgi FM, Ray F Correcting under-reported COVID-19 case numbers: estimating the true scale of the pandemic. medRxiv 2020.03.14.20036178. https://doi.org/10.1101/2020.03.14.20036178

Republic of Korea Center of Disease Control. Updates on COVID-19 in Republic of Korea, 3/13/2020.

Giovannoni G, Comi G, Cook S et al (2010) A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. N Engl J Med 362:416–426CrossRefPubMedCentral

Cohen JA, Coles AJ, Arnold DL et al (2012) Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial. Lancet 380:1819–1828CrossRefPubMedCentral

Title: Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study
Authors: Gloria Dalla Costa
Letizia Leocani
Xavier Montalban
Ana Isabel Guerrero
Per Soelberg Sørensen
Melinda Magyari
Richard J. B. Dobson
Nicholas Cummins
Vaibhav A. Narayan
Matthew Hotopf
Giancarlo Comi
on behalf of the RADAR-CNS consortium
Publication date: 01-07-2020
Publisher: Springer International Publishing
Keywords: Multiple Sclerosis
COVID-19
Glatiramer acetate
Teriflunomide
Alemtuzumab
Cladribine
Alemtuzumab
Anosmia
Published in: Neurological Sciences / Issue 7/2020
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-020-04519-x

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2020

Dysphasia is associated with diffusion-weighted MRI abnormalities in patients with transient neurological symptoms

Selection of treatment for ictal asystole patients based on EEG and ECG with temporary cardiac pacing

Highlights of the issue 7, 2020

Pallidal dementia with underlying sleep apnea syndrome: a case report and literature review

Impact of brain atrophy on tDCS and HD-tDCS current flow: a modeling study in three variants of primary progressive aphasia

Neuromuscular diseases rehabilitation in the era of gene therapy